---
title: "CVKD.US (CVKD.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CVKD.US/news.md"
symbol: "CVKD.US"
name: "CVKD.US"
parent: "https://longbridge.com/zh-CN/quote/CVKD.US.md"
datetime: "2026-03-16T12:54:58.057Z"
locales:
  - [en](https://longbridge.com/en/quote/CVKD.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CVKD.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CVKD.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/CVKD.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CVKD.US/news.md)


# CVKD.US (CVKD.US) — 相关新闻

### [Cadrenal Highlights CAD-1005 Preclinical Data in Metabolic Disease](https://longbridge.com/zh-CN/news/278886449.md)
*2026-03-12T12:39:32.000Z*
> Cadrenal Highlights CAD-1005 Preclinical Data in Metabolic Disease

### [Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes](https://longbridge.com/zh-CN/news/278882385.md)
*2026-03-12T12:02:46.000Z*
> In Ponte Vedra, Florida, on March 12, 2026, Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) shared promising scientific disco

### [U.S. stock market midday update: Cadrenal Therapeutics up 8.99%, Phase II trial success and FDA approval boost market confidence](https://longbridge.com/zh-CN/news/276931560.md)
*2026-02-25T19:47:55.000Z*
> Cadrenal Therapeutics rose 8.99%; Novo Nordisk fell 1.83%, with a trading volume of USD 1.652 billion; Eli Lilly fell 1.

### [](https://longbridge.com/zh-CN/news/276778805.md)
*2026-02-24T19:20:17.000Z*
> Cadrenal Therapeutics shares are trading higher after the company announced results from a Phase 2 trial evaluating CAD-

### [US Stock Movement Update: Abits surged 163.29%, Rackspace Tech rose 64.49%, Twin Vee PowerCats fell 54.59%](https://longbridge.com/zh-CN/news/276477237.md)
*2026-02-20T19:00:19.000Z*
> Overview of the US Stock Market: The current market shows a clear divergence between strengths and weaknesses, with tech

### [Cadrenal Therapeutics Presents VLX-1005 Data at Lytham Partners 2026 Investor Healthcare Summit](https://longbridge.com/zh-CN/news/272274106.md)
*2026-01-12T13:03:55.000Z*
### [Cadrenal Therapeutics CFO Matthew K. Szot Reports Disposal of Common Shares](https://longbridge.com/zh-CN/news/271244645.md)
*2025-12-31T21:06:14.000Z*
### [Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On](https://longbridge.com/zh-CN/news/270997358.md)
*2025-12-29T13:00:00.000Z*
> Cadrenal Therapeutics is focusing on the neglected areas of anticoagulation, targeting patients with complex conditions